LMAT LeMaitre: רווח למניה ב-12 החודשים האחרונים

LeMaitre Vascular, Inc. (LMAT) dominates vascular implant niches due to surgeon loyalty to its unique shunts. The trailing twelve-month EPS dynamics link this success to robotic production lines where machine vision eliminates defects. The 17.80 mark reflects fresh data, confirming the financial stability of the business's cash cow, whose cash flow is supported by a steady schedule of planned operations.
פילוחי מדדים פיננסיים ומדדי שוק עבור LeMaitre Corp (LMAT)

This indicator measures the dynamics of net earnings per share over a rolling year, allowing investors to assess the scaling pace of the business's actual earnings. By analyzing the annual percentage change in earnings per share (TTM), one can confirm the effectiveness of the pricing power of LeMaitre Vascular, Inc. (LMAT) within the vascular surgery segment and the impact of expanding global sales on the issuer's bottom-line profitability.